Crown Castle Inc (CCI) concluded trading on Wednesday at a closing price of $105.76, with 3.93 million shares of worth about $415.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.89% during that period and on April 30, 2025 the price saw a gain of about 1.99%. Currently the company’s common shares owned by public are about 435.00M shares, out of which, 434.28M shares are available for trading.
Stock saw a price change of 3.40% in past 5 days and over the past one month there was a price change of 1.47%. Year-to-date (YTD), CCI shares are showing a performance of 16.53% which increased to 13.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $84.20 but also hit the highest price of $120.92 during that period. The average intraday trading volume for Crown Castle Inc shares is 3.40 million. The stock is currently trading 4.84% above its 20-day simple moving average (SMA20), while that difference is up 6.47% for SMA50 and it goes to 2.76% higher than SMA200.
Crown Castle Inc (NYSE: CCI) currently have 435.00M outstanding shares and institutions hold larger chunk of about 93.75% of that.
The stock has a current market capitalization of $46.05B and its 3Y-monthly beta is at 0.94. It has posted earnings per share of -$8.97 in the same period. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCI, volatility over the week remained 2.34% while standing at 3.44% over the month.
Stock’s fiscal year EPS is expected to rise by 110.07% while it is estimated to increase by 197.95% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on March 20, 2025 offering a Neutral rating for the stock and assigned a target price of $110 to it. On March 17, 2025, Wells Fargo Upgrade their recommendations, while on March 14, 2025, UBS Upgrade their ratings for the stock with a price target of $118. Stock get a Strong buy rating from Raymond James on March 14, 2025.
